172 related articles for article (PubMed ID: 37219665)
1. Inhibiting eukaryotic initiation factor 5A (eIF5A) hypusination attenuated activation of the SIK2 (salt-inducible kinase 2)-p4E-BP1 pathway involved in ovarian cancer cell proliferation and migration.
Lee GK; Kim HY; Park JH
Mol Biol Rep; 2023 Jul; 50(7):5807-5816. PubMed ID: 37219665
[TBL] [Abstract][Full Text] [Related]
2. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Eukaryotic Translation Initiation Factor 5A (eIF5A) Hypusination Suppress p53 Translation and Alters the Association of eIF5A to the Ribosomes.
Martella M; Catalanotto C; Talora C; La Teana A; Londei P; Benelli D
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605139
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic initiation factor 5A hypusine as a negative regulator of adenosine 2B receptor (A2bAR) through interaction with stem loop sequences within the A2bAR 3'-untranslated region.
Lee GK; Kim CW; Cho IH; Kim HY; Park JH
Mol Biol Rep; 2023 Apr; 50(4):3099-3109. PubMed ID: 36689050
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma.
Lee NP; Tsang FH; Shek FH; Mao M; Dai H; Zhang C; Dong S; Guan XY; Poon RT; Luk JM
Int J Cancer; 2010 Aug; 127(4):968-76. PubMed ID: 19998337
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic translation initiation factor 5A (eIF5A) is essential for HIF-1α activation in hypoxia.
Tariq M; Ito A; Ishfaq M; Bradshaw E; Yoshida M
Biochem Biophys Res Commun; 2016 Feb; 470(2):417-424. PubMed ID: 26773503
[TBL] [Abstract][Full Text] [Related]
7. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation.
Liu Y; Xue F; Zhang Y; Lei P; Wang Z; Zhu Z; Sun K
Anticancer Drugs; 2017 Nov; 28(10):1097-1105. PubMed ID: 28885268
[TBL] [Abstract][Full Text] [Related]
8. LHCGR Expression During Follicle Stimulating Hormone-Induced Follicle Growth Is Negatively Regulated by Eukaryotic Initiation Factor 5A.
Gulappa T; Menon B; Menon KMJ
Endocrinology; 2017 Aug; 158(8):2672-2679. PubMed ID: 28605466
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.
Xu G; Yu H; Shi X; Sun L; Zhou Q; Zheng D; Shi H; Li N; Zhang X; Shao G
BMC Pulm Med; 2014 Nov; 14():174. PubMed ID: 25380840
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of eIF5A results in aberrant uterine natural killer cell function and embryo loss in mice.
Qin X; Liu X; Shan B; Shi L; Sharma S; Wu J; Lin Y
Am J Reprod Immunol; 2014 Mar; 71(3):229-40. PubMed ID: 24382123
[TBL] [Abstract][Full Text] [Related]
11. Targeting eIF5A Hypusination Prevents Anoxic Cell Death through Mitochondrial Silencing and Improves Kidney Transplant Outcome.
Melis N; Rubera I; Cougnon M; Giraud S; Mograbi B; Belaid A; Pisani DF; Huber SM; Lacas-Gervais S; Fragaki K; Blondeau N; Vigne P; Frelin C; Hauet T; Duranton C; Tauc M
J Am Soc Nephrol; 2017 Mar; 28(3):811-822. PubMed ID: 27612998
[TBL] [Abstract][Full Text] [Related]
12. The role of eIF5A in epidermal growth factor-induced proliferation of corneal epithelial cell association with PI3-k/Akt activation.
Ding L; Gao LJ; Gu PQ; Guo SY; Cai YQ; Zhou XT
Mol Vis; 2011 Jan; 17():16-22. PubMed ID: 21224998
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of eIF5A hypusination pathway as a new pharmacological target for stroke therapy.
Bourourou M; Gouix E; Melis N; Friard J; Heurteaux C; Tauc M; Blondeau N
J Cereb Blood Flow Metab; 2021 May; 41(5):1080-1090. PubMed ID: 32615885
[TBL] [Abstract][Full Text] [Related]
14. The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells.
Liu Z; Teng L; Gao L; Wang H; Su Y; Li J
Biochem Biophys Res Commun; 2018 Sep; 504(1):6-12. PubMed ID: 30170728
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of eukaryotic translation initiation factor 5A (eIF5A) hypusination impairs melanoma growth.
Jasiulionis MG; Luchessi AD; Moreira AG; Souza PP; Suenaga AP; Correa M; Costa CA; Curi R; Costa-Neto CM
Cell Biochem Funct; 2007; 25(1):109-14. PubMed ID: 16850525
[TBL] [Abstract][Full Text] [Related]
16. Insulin action on protein synthesis and its association with eIF5A expression and hypusination.
de Proença ARG; Pereira KD; Meneguello L; Tamborlin L; Luchessi AD
Mol Biol Rep; 2019 Feb; 46(1):587-596. PubMed ID: 30519811
[TBL] [Abstract][Full Text] [Related]
17. Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation.
Coni S; Serrao SM; Yurtsever ZN; Di Magno L; Bordone R; Bertani C; Licursi V; Ianniello Z; Infante P; Moretti M; Petroni M; Guerrieri F; Fatica A; Macone A; De Smaele E; Di Marcotullio L; Giannini G; Maroder M; Agostinelli E; Canettieri G
Cell Death Dis; 2020 Dec; 11(12):1045. PubMed ID: 33303756
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells.
Fang L; Gao L; Xie L; Xiao G
J Cancer; 2018; 9(19):3479-3488. PubMed ID: 30310504
[No Abstract] [Full Text] [Related]
19. Eukaryotic initiation factor 5A plays an essential role in luteinizing hormone receptor regulation.
Menon B; Gulappa T; Menon KM
Mol Endocrinol; 2014 Nov; 28(11):1796-806. PubMed ID: 25216047
[TBL] [Abstract][Full Text] [Related]
20. The protein synthesis inhibitor brusatol normalizes high-fat diet-induced glucose intolerance in male C57BL/6 mice: role of translation factor eIF5A hypusination.
Turpaev K; Krizhanovskii C; Wang X; Sargsyan E; Bergsten P; Welsh N
FASEB J; 2019 Mar; 33(3):3510-3522. PubMed ID: 30462531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
